| 000 | 01798 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516135731.0 | ||
| 264 | 0 | _c20140319 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1093/cid/cit112 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMurray, Kyle P | |
| 245 | 0 | 0 |
_aEarly use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cJun 2013 |
||
| 300 |
_a1562-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacteremia _xdrug therapy |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDaptomycin _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVancomycin _xpharmacology |
| 700 | 1 | _aZhao, Jing J | |
| 700 | 1 | _aDavis, Susan L | |
| 700 | 1 | _aKullar, Ravina | |
| 700 | 1 | _aKaye, Keith S | |
| 700 | 1 | _aLephart, Paul | |
| 700 | 1 | _aRybak, Michael J | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 56 _gno. 11 _gp. 1562-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/cit112 _zAvailable from publisher's website |
| 999 |
_c22542262 _d22542262 |
||